Browse by Year
/ 2009
/ January
/ Friday, January 02, 2009
[Federal Register: January 2, 2009 (Volume 74, Number 1)]
[Rules and Regulations]
[Page 6]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr02ja09-3]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 558
[Docket No. FDA-2008-N-0039]
New Animal Drugs for Use in Animal Feeds; Tiamulin
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is amending the animal
drug regulations to reflect approval of two supplemental new animal
drug applications (NADAs) filed by Novartis Animal Health US, Inc. The
supplemental NADAs provide for removal of a 250-pound weight
restriction and the addition of a reproductive caution statement to
labeling of tiamulin medicated feeds used for the treatment or control
of certain bacterial enteric diseases in swine.
DATES: This rule is effective January 2, 2009.
FOR FURTHER INFORMATION CONTACT: Cindy L. Burnsteel, Center for
Veterinary Medicine (HFV-130), Food and Drug Administration, 7500
Standish Pl., Rockville, MD 20855, 240-276-8341, e-mail:
cindy.burnsteel@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Novartis Animal Health US, Inc., 3200
Northline Ave., suite 300, Greensboro, NC 27408, filed a supplement to
NADA 139-472 for DENAGARD (tiamulin) Medicated Premixes used for the
treatment or control of certain bacterial enteric diseases in swine.
Novartis Animal Health US, Inc., also filed a supplement to NADA 141-
011 for the use of DENAGARD (tiamulin) Medicated Premixes and
Chlortetracycline Type A medicated articles to manufacture 2-way
combination drug medicated swine feeds used for the treatment or
control of certain bacterial enteric diseases. The supplemental NADAs
provide for removal of a 250-pound weight restriction and the addition
of a reproductive caution statement to labeling. The supplemental NADAs
are approved as of December 9, 2008, and 21 CFR 558.600 is amended to
reflect the approval.
Approval of these supplemental NADAs did not require review of
additional safety or effectiveness data or information. Therefore, a
freedom of information summary is not required.
The agency has determined under 21 CFR 25.33 that these actions are
of a type that do not individually or cumulatively have a significant
effect on the human environment. Therefore, neither an environmental
assessment nor an environmental impact statement is required.
This rule does not meet the definition of ``rule'' in 5 U.S.C.
804(3)(A) because it is a rule of ``particular applicability.''
Therefore, it is not subject to the congressional review requirements
in 5 U.S.C. 801 808.
List of Subjects in 21 CFR Part 558
Animal drugs, animal feeds.
0
Therefore, under the Federal Food, Drug, and Cosmetic Act and under
authority delegated to the Commissioner of Food and Drugs and
redelegated to the Center for Veterinary Medicine, 21 CFR part 558 is
amended as follows:
PART 558--NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS
0
1. The authority citation for 21 CFR part 558 continues to read as
follows:
Authority: 21 U.S.C. 360b, 371.
0
2. In Sec. 558.600, revise paragraphs (d)(2) and (e)(1)(i) to read as
follows:
Sec. 558.600 Tiamulin.
* * * * *
(d) * * *
(2) The effects of tiamulin on swine reproductive performance,
pregnancy, and lactation have not been determined.
* * * * *
(e) * * *
(1) * * *
----------------------------------------------------------------------------------------------------------------
Combination in
Tiamulin grams per ton grams per ton Indications for use Limitations Sponsor
----------------------------------------------------------------------------------------------------------------
(i) 10........................ ................... For increased rate Feed continuously 058198
of weight gain and as the sole
improved feed ration. Not for
efficiency. use in swine
weighing over 250
pounds.
----------------------------------------------------------------------------------------------------------------
* * * * * * *
----------------------------------------------------------------------------------------------------------------
* * * * *
Dated: December 22, 2008.
Steven D. Vaughn,
Director, Office of New Animal Drug Evaluation, Center for Veterinary
Medicine.
[FR Doc. E8-31128 Filed 12-31-08; 8:45 am]
BILLING CODE 4160-01-S
Browse by Year
/ 2009
/ January
/ Friday, January 02, 2009
|
|